Acetyl-Histone H3 (Lys14) Antibody is a polyclonal rabbit antibody targeting histone H3 acetylated at lysine 14 (H3K14ac), a post-translational modification associated with transcriptional activation . Histone H3 is a core component of nucleosomes, which compact DNA into chromatin. Acetylation at Lys14 reduces DNA-histone interactions, increasing chromatin accessibility for transcriptional machinery .
Used to detect H3K14ac levels in acid-extracted histones, providing insights into chromatin states during differentiation or disease .
Visualizes H3K14ac localization in nuclei, correlating acetylation patterns with transcriptional activity .
Quantifies H3K14ac levels using a sandwich assay:
Capture: Monoclonal anti-histone H3 antibody immobilizes histones.
Detection: Polyclonal anti-H3K14ac antibody binds specifically, followed by HRP-conjugated secondary antibody for colorimetric analysis .
Higher sensitivity (detects low-abundance modifications).
Faster results (<3 hours).
Specificity Testing: No cross-reactivity with non-acetylated H3 or other acetylated residues (e.g., H3K9ac, H3K27ac) .
Blocking Peptide Validation: A synthetic acetylated peptide (1–50 aa) confirms antibody specificity by abolishing signal in competition assays .
Formulation: Purified via affinity chromatography, ensuring >90% purity .
H3K14ac is enriched at promoters of actively transcribed genes, serving as a marker for open chromatin. Studies link its levels to:
H3K14ac facilitates recruitment of bromodomain-containing proteins (e.g., BRD4), which mediate transcriptional elongation .
Histone H3 acetylated at lysine 14 (H3K14ac) is a specific post-translational modification of histone H3 that plays a crucial role in transcriptional regulation. This modification has been correlated with the regulation of gene transcription, making it a significant marker in studying transcriptional activity. H3K14 acetylation corresponds to transcriptional activation and has been mapped to the initiation sites of actively transcribed genes .
The acetylation of H3K14 alters chromatin structure by neutralizing the positive charge of lysine, reducing the electrostatic interaction between histones and negatively charged DNA, thereby facilitating access of transcription machinery to DNA.
H3K14 acetylation functions within a complex network of histone modifications. Research indicates that H3K14ac can influence and be influenced by other modifications:
| Modification | Relationship with H3K14ac | Functional Outcome |
|---|---|---|
| H3K4me3 | Often co-occurs | Enhanced transcriptional activation |
| H3K9ac | Frequently present together | Associated with active promoters |
| H3K9me3 | Generally mutually exclusive | H3K14ac counteracts repressive effects |
| H3K36me2 | Complex interaction | Can affect elongation phase of transcription |
The CoREST complex (LHC) demethylase activity toward methyl-Lys4 in histone H3 is strongly inhibited by H3 Lys14 acetylation, demonstrating how this acetylation can protect activating marks from removal .
Acetyl-Histone H3 (Lys14) antibodies are employed in numerous research applications:
For optimal ChIP results, researchers typically use 10 μl of antibody and 10 μg of chromatin (approximately 4 x 10^6 cells) per immunoprecipitation .
Histone H3 acetyl Lys14 ELISA provides a sensitive, quantitative method for measuring H3K14ac levels:
Sandwich ELISA methodology:
Sensitivity and range:
Advantages over immunoblotting:
For standardization, recombinant Histone H3 acetyl Lys14 protein (99% pure) can be used to build reference standard curves .
Validating antibody specificity is critical for accurate experimental results. Multiple approaches are used:
Cross-reactivity testing with peptide arrays:
Dot blot analysis:
Western blot validation:
ChIP-PCR of known targets:
Epitope occlusion phenomena:
Some antibodies may show reduced binding if nearby residues are modified
For example, phosphorylation of serine 10 (S10ph) might affect binding of some H3K14ac antibodies
Validating antibody in context-specific manner:
When studying highly modified chromatin regions, antibody binding efficiency should be verified
Synthetic peptides with combinations of modifications can be used to test for interference
Quantitative considerations:
Signal strength may vary depending on the modification status of surrounding residues
Control experiments with defined modification patterns are recommended for quantitative studies
The interaction between H3K14ac and chromatin-modifying enzyme complexes reveals sophisticated regulatory mechanisms:
CoREST complex interaction:
Selective deacetylation patterns:
The deacetylase selectivity of LHC shows marked preference for H3 acetyl-Lys9 versus acetyl-Lys14 in nucleosome substrates
This selectivity is lost with isolated acetyl-Lys H3 protein, suggesting nucleosome context is important
The diminished activity toward Lys-14 deacetylation in nucleosomes is not merely due to steric accessibility
These findings indicate H3K14ac functions as a protective mark that confers resistance to certain enzyme complexes, potentially stabilizing active transcriptional states.
ChIP-seq studies have revealed distinctive distribution patterns of H3K14ac:
Promoter enrichment:
H3K14ac is predominantly found at promoters of actively transcribed genes
Often co-occurs with H3K4me3 and RNA Polymerase II occupancy
Cell-type specific patterns:
Distribution varies between cell types, reflecting differential gene expression
Changes in H3K14ac patterns correlate with developmental transitions
Response to stimuli:
Rapid changes in H3K14ac distribution occur in response to stimuli
For example, stress conditions can induce global changes in acetylation patterns
Species-specific considerations:
Understanding these genome-wide patterns helps elucidate the role of H3K14ac in transcriptional regulation across different biological contexts.
Researchers frequently encounter specific challenges when using H3K14ac antibodies:
| Challenge | Potential Solution |
|---|---|
| High background in ChIP | Pre-clear chromatin, use more stringent washing, optimize antibody amount |
| Weak signal in Western blots | Confirm extraction method preserves acetylation, increase protein loading, use HDAC inhibitors |
| Inconsistent ChIP-seq results | Ensure antibody lot consistency, include spike-in controls, normalize data appropriately |
| Cross-reactivity concerns | Validate with peptide competition assays, compare results with multiple antibody clones |
| Signal variability between experiments | Use recombinant H3K14ac standards, include internal controls, standardize protocols |
For ChIP applications specifically, researchers should:
Use the recommended amount of antibody (typically 10 μl) and chromatin (10 μg)
Include appropriate positive and negative controls
Consider using validated ChIP kits that have been tested with H3K14ac antibodies
Advanced research often requires integration of multiple epigenetic datasets:
Multivariate analysis approaches:
Chromatin state modeling using hidden Markov models
Genome segmentation based on combinations of marks
Correlation analysis between H3K14ac and other modifications
Sequential ChIP methodology:
First immunoprecipitate with H3K14ac antibody
Re-ChIP the material with antibody against another modification
Identifies genomic regions containing both modifications simultaneously
Mass spectrometry integration:
Complementing ChIP data with mass spectrometry analysis
Provides quantitative information about co-occurring modifications
Can reveal combinatorial patterns not detectable by individual ChIP experiments
Functional validation experiments:
CRISPR-based recruitment of histone acetyltransferases
Site-directed mutagenesis of K14 residue
Inhibitor studies targeting specific enzymes that modify H3K14
By combining these approaches, researchers can develop more complete models of how H3K14ac functions within the broader epigenetic landscape to regulate gene expression and chromatin structure.
For accurate analysis of histone acetylation at H3K14, proper extraction and sample preparation is crucial:
Acid extraction protocol:
Harvest cells and wash with ice-cold PBS
Resuspend cell pellet in Triton Extraction Buffer (PBS containing 0.5% Triton X-100, 2mM PMSF, 0.02% NaN₃)
Lyse cells on ice for 10 minutes with gentle stirring
Centrifuge at 6,500 × g for 10 minutes at 4°C
Resuspend pellet in 0.2N HCl
Incubate overnight at 4°C with rotation
Centrifuge at 6,500 × g for 10 minutes at 4°C
Transfer supernatant to a new tube
Neutralize with 1/10 volume of 2M NaOH
Critical considerations:
Include HDAC inhibitors (sodium butyrate at 5-10 mM or Trichostatin A at 0.3-0.4 μM) in all buffers
Use protease inhibitor cocktails to prevent degradation
Maintain cold temperatures throughout the procedure
Process samples quickly to minimize loss of modifications
These extraction methods are compatible with various downstream applications including ELISA, which can detect H3K14ac within a range of 0.03 to 1 micrograms of acid extract .
Proper experimental controls are essential for reliable H3K14ac research:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive control | Verify antibody functionality | Use cells treated with HDAC inhibitors (sodium butyrate, Trichostatin A) |
| Negative control | Establish background levels | Use IgG from same species as H3K14ac antibody |
| Input control | Normalize for DNA abundance | Process aliquot of starting material without immunoprecipitation |
| Peptide competition | Confirm antibody specificity | Pre-incubate antibody with H3K14ac peptide before experiment |
| Recombinant standards | Enable quantitation | Include recombinant H3K14ac protein standard curve |
For ChIP experiments specifically:
Include genomic regions known to be enriched for H3K14ac (positive loci)
Include genomic regions known to lack H3K14ac (negative loci)
Consider using spike-in chromatin from different species for normalization
Recombinant Histone H3 acetyl Lys14 protein (99% pure) is available with some ELISA kits and can be used to build reference standard curves for accurate quantitation .
Analysis of H3K14ac ChIP-seq data requires specific computational approaches:
Primary analysis pipeline:
Quality control: FastQC to assess sequence quality
Alignment: Map reads to reference genome (Bowtie2, BWA)
Peak calling: Identify enriched regions (MACS2, SICER)
Visualization: Generate coverage tracks (deepTools, IGV)
Integration strategies:
Correlation with gene expression data (RNA-seq)
Overlap with other histone modifications (bedtools, ChromHMM)
Motif enrichment analysis to identify associated transcription factors
Pathway analysis of genes associated with H3K14ac peaks
Multi-omics integration example:
Advanced normalization approaches:
Spike-in normalization for comparing conditions
Quantile normalization for batch correction
Signal extraction scaling (SES) for antibody efficiency differences
These approaches enable researchers to extract maximum biological insight from H3K14ac ChIP-seq datasets and place findings in broader genomic context.
Recent technological advances are providing new insights into H3K14ac:
CUT&RUN and CUT&Tag alternatives to ChIP:
Improved signal-to-noise ratio compared to conventional ChIP
Requires fewer cells (down to 1,000)
More sensitive detection of H3K14ac in limited samples
Reduced background compared to ChIP-seq
Single-cell approaches:
scCUT&Tag for single-cell profiling of H3K14ac
Reveals cell-to-cell heterogeneity in acetylation patterns
Can be integrated with scRNA-seq for multi-omic analysis
Live-cell imaging of H3K14ac:
Antibody-based fluorescent probes
Engineered reader domains that specifically recognize H3K14ac
Enables real-time monitoring of acetylation dynamics
Mass spectrometry advancements:
Quantitative analysis of combinatorial histone modifications
Middle-down MS approaches that preserve longer histone tail fragments
Can identify co-occurrence of H3K14ac with other modifications on the same histone molecule
CRISPR-based epigenome editing:
Targeted modification of H3K14ac at specific loci
dCas9 fused to histone acetyltransferases or deacetylases
Allows causal testing of H3K14ac function at specific genomic locations
These technologies are expanding our understanding of H3K14ac beyond static snapshots to dynamic, site-specific, and single-cell resolution views of its function.
H3K14 acetylation shows dynamic responses to various stimuli:
Stress response patterns:
Signaling pathway integration:
Temporal dynamics:
H3K14ac changes can occur rapidly (within minutes) after stimulus
Different genes show distinct temporal patterns of acetylation
Some changes are transient while others are sustained
Therapeutic implications:
These findings highlight H3K14ac as a dynamic epigenetic mark that integrates various cellular signals and environmental conditions.
H3K14 acetylation has been implicated in various disease contexts:
Cancer epigenetics:
Altered H3K14ac patterns observed in multiple cancer types
Can serve as a biomarker for disease progression
Target of epigenetic therapies including HDAC inhibitors
Neurodevelopmental conditions:
Infectious disease:
Therapeutic monitoring applications:
Changes in H3K14ac can be monitored to assess efficacy of epigenetic therapies
ELISAs provide quantitative tools for measuring these changes in clinical samples
Specific antibodies enable precise targeting of this modification in diagnostic applications